Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany
Pubblicato in: | Journal of Critical Care 66(2021)S. 187-188 |
---|---|
Autori principali: | Köhler, Thomas (Autore), Schwier, Elke (Autore), Henzler, Dietrich (Autore), Eickmeyer, Claas (Autore) |
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
2021
|
Soggetti: | |
Accesso online: | https://doi.org/10.1016/j.jcrc.2021.07.011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314144/ |
Documenti correlati: | In:
Journal of Critical Care |
Documenti analoghi
-
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
di: Schultz, Philipp, et al.
Pubblicazione: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
di: Hawchar, Fatime, et al.
Pubblicazione: (2022) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
di: Köhler, Thomas, et al.
Pubblicazione: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
di: Köhler, Thomas, et al.
Pubblicazione: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
di: Unterberg, Matthias, et al.
Pubblicazione: (2022)